Mira Pharmaceuticals MIRA Cash Flow Statement (2022-2025)

NASDAQ MIRA

$0.76 +0.03 (+4.60%)

At close: Aug 21, 2026 · 4:00 PM EDT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Share-based Compensation (Quarter)	0.15M	0.15M	0.15M	1.70M	1.50M	0.21M	0.50M	0.60M	0.50M	0.55M	0.40M		0.12M	4.56M
Cash from Operations (Quarter)	-1.31M	-0.98M	-1.08M	-0.66M	-1.76M	-1.04M	-1.05M	-0.86M	-1.84M	-1.81M	-1.63M	-0.77M	-1.10M	-1.20M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)					0.44M
Change in Working Capital
Change in Accured Expenses (Quarter)	0.35M	0.17M	0.18M	-0.45M	0.12M	-0.24M	0.10M	0.15M	-0.09M	0.03M	-0.62M	0.19M	-0.21M	0.05M
Financing Activities
Other financing activities (Quarter)									0.10M	-1.17M				0.59M
Cash from Financing Activities (Quarter)	0.68M	1.14M	0.73M	0.68M	7.60M	-0.23M	-0.02M	0.16M	3.16M	0.49M	0.00M	0.32M	3.01M	4.84M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)	0.90M	0.28M								0.48M	0.00M	0.35M	2.82M	3.84M
Dividend Payments
Dividends Paid - Common (Quarter)							0.02M	-0.01M
Additional items
Change in Cash (Quarter)	-0.64M	0.16M	-0.35M	0.02M	5.84M	-1.27M	-1.07M	-0.70M	1.32M	-1.31M	-1.63M	-0.48M	1.91M	3.71M
Free Cash Flow (Quarter)	-1.31M	-0.98M	-1.08M	-0.66M	-1.76M	-1.04M	-1.05M	-0.86M	-1.84M	-1.81M	-1.63M	-0.77M	-1.10M	-1.20M
Net Cash Flow (Quarter)	-0.64M	0.16M	-0.35M	0.02M	5.84M	-1.27M	-1.07M	-0.70M	1.32M	-1.31M	-1.63M	-0.45M	1.91M	3.64M

Mira Pharmaceuticals (MIRA)

NASDAQ: MIRA

$0.76 ▲ +0.03 (+4.60%)

Aug 21, 2026 · 4:00 PM EDT